Related Experiment Video
Updated: Aug 6, 2026

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
Published on: August 17, 2014
Central corneal thickness and vascular risk factors in normal tension glaucoma
Aoife Doyle1, Ahmed Bensaid, Yves Lachkar
1L'Institut du Glaucome, Fondation Hôpital St. Joseph, Paris, France.
Background:
Normal tension glaucoma (NTG) has been shown to be associated with reduced central corneal thickness (CCT). The association of NTG with vascular risk factors is well documented. It has been postulated that a subset of NTG patients are misclassified due to incorrect intraocular pressure measurements on thin corneas. The aim of this study was to establish whether corneal thickness in NTG differs between patients with vascular risk factors specific to NTG and those without.
Methods:
The study comprised a retrospective analysis of 108 eyes of 54 patients with NTG and 54 patients with primary open-angle glaucoma (POAG). Corneal thickness was measured in all patients. Vascular risk factors were recorded. Patients with NTG were divided into two groups depending on the presence (group A) or absence (group B) of vascular risk factors.
Results:
The mean CCT was 549 +/- 34 microm in patients with POAG and 528 +/- 31 microm in patients with NTG (p = 0.001). Mean CCT was 512 +/- 31 microm in group A (n = 13) and 533 +/- 31 microm in group B (n = 41) (p = 0.034). A total of 40.9% of those with thin corneas (n = 22) had vascular risk factors versus only 12.5% of those with CCT within the normal range (n = 32) (p < 0.05).
Conclusion:
Central corneal thickness in NTG was significantly lower than in POAG and corneas were thinner in NTG patients with vascular risk factors than in those without. Vascular risk factors were significantly more common in patients with thin corneas. The finding of reduced corneal thickness in NTG does not obviate the need to consider vascular risk factors in the pathophysiology of the disease.
More Related Videos
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Diabetic Retinopathy

